Author Topic: POIS 2021-2022 NORD RESEARCH STUDY  (Read 35249 times)

demografx

  • Administrator
  • Hero Member
  • *****
  • Posts: 5548
  • All of us working together to defeat POIS!
Re: POIS 2021-2022 NORD RESEARCH STUDY
« Reply #400 on: June 11, 2021, 11:53:56 PM »

Hi, everyone,

Research Study suggestions that we have at this forum (such as those you have made in this thread) must go through an extensive vetting process with the IRB,

The Institutional Review Board (IRB) is an administrative body established to protect the rights and welfare of human research subjects recruited to participate in research activities conducted under the auspices of the institution with which it is affiliated.

In our case, it’s the UNL (University of Nebraska - Lincoln) IRB

which would create a disproportionate delay for  every considered change, regardless of how small. The protocol has been established now and we just need to move forward with the methodology already in place.

In discussing the above with the POIS Research Team, they shared this:

“While it’s good to suggest routes for potential research studies, each individual study needs to focus on a few things at a time to be able to make any headway. The research must go through an extensive vetting process with the IRB and biological safety committees, which would create a disproportionate delay for every considered change, regardless of how small. And the grant agency has already approved the proposed factors that will be studied in this particular study. So while we don’t discourage anyone from speculating about possible factors to investigate in the future, for the study that is already underway, it will not be possible to make changes to what factors we are focusing on."

Have a nice weekend!
Demo
10 years of significant POIS-reduction, treatment consisting of daily (365 days/year) testosterone patches.

TRT must be checked out carefully with your doctor due to fertility, cardiac and other risks.

40+ years of severe 4-days-POIS, married, raised a family, started/ran a business